Abstract
The claim that anti-malaria drugs, chloroquine and hydroxychloroquine, can cure COVID-19 became a focus of fierce political battles that pitted promoters of these pharmaceuticals, Presidents Bolsonaro and Trump among them, against "medical elites." At the center of these battles are different meanings of effectiveness in medicine, the complex role of randomized clinical trials (RCTs) in proving such effectiveness, the task of medical experts and the state in regulating pharmaceuticals, patients' activism, and the collective production of medical knowledge. This article follows the trajectory of chloroquine and hydroxychloroquine as anti-COVID-19 drugs, focusing on the reception of views of their main scientific promoter, the French infectious disease specialist, Didier Raoult. The surprising career of these drugs, our text proposes, is fundamentally a political event, not in the narrow sense of engaging specific political fractions, but in the much broader sense of the politics of public participation in science.
References
Dec 19, 1992·BMJ : British Medical Journal·R Doll
Sep 19, 1997·The New England Journal of Medicine·M Angell
Oct 2, 1997·The New England Journal of Medicine·H Varmus, D Satcher
Jul 14, 2001·The New England Journal of Medicine·H T Shapiro, E M Meslin
Jan 1, 1985·Journal of Contemporary History·C Lawrence
Oct 1, 1995·Science, Technology & Human Values·Steven Epstein
Dec 19, 2003·International Journal of Epidemiology·Peter Armitage
Dec 19, 2003·International Journal of Epidemiology·Harry M Marks
Feb 21, 2004·The Journal of Infectious Diseases·Ezekiel J EmanuelChristine Grady
Apr 15, 2004·International Journal of Epidemiology·Iain Chalmers, Mike Clarke
Jul 21, 2010·Science·Quarraisha Abdool KarimUNKNOWN CAPRISA 004 Trial Group
Oct 18, 2011·Current HIV/AIDS Reports·Douglas Krakower, Kenneth H Mayer
Mar 5, 2016·Journal of Clinical Epidemiology·John P A Ioannidis
Apr 11, 2020·The New England Journal of Medicine·Jonathan GreinTimothy Flanigan
Apr 25, 2020·JAMA Network Open·Mayla Gabriela Silva BorbaUNKNOWN CloroCovid-19 Team
Apr 28, 2020·JAMA Network Open·Mayla Gabriela Silva BorbaUNKNOWN CloroCovid-19 Team
May 20, 2020·Lancet·Yeming WangChen Wang